Impact of demonetisation on pharma industry
Amit Mookim, GM, South Asia, QuintilesIMS, explains how digital way will not only benefit the customers but also the overall…
Author
Neurodegenerative drugs mkt set to hit $45 bn by 2022
According to GBI Research, much of the growth is expected due to the approval of many products
Trends in 2017
What will be the most dominant business trends in the pharmaceutical sector in the year ahead?
Where the mind is without fear…
TK Kanchana, Director-General, Organisation of Pharmaceutical Producers of India (OPPI) talks about the trends which are most…
A year of opportunities and challenges
Vikas Bhadoria, Senior Partner, Mc Kinsey and Vivek Arora, Associate Partner, Mc Kinsey, talk about how the global industry is at…
Business trends in 2017
Utkarsh Palnitkar, Partner, National Head – Infrastructure, Government & Healthcare and National Head – Life Sciences…
Dominant business trends in 2017
Ameesh Masurekar, Director, AIOCD Pharmasofttech AWACS, talks about the prevalence of online retail, therapeutic and regulatory…
Indian pharma landscape in 2017
Antal International takes a closer look at the business trends that could be game changers for India's growing pharmaceutical…
Pharma cos need to realign biz models
Pharma companies should focus on high-performing therapeutic area and geographic markets and they need to realign their business…